Israel Section 102: Equity Plan Pitfalls to Avoid

Navigating Israel Section 102: Key Plan Design Pitfalls and Tax Considerations

Section 102 of Israel’s Income Tax Ordinance offers a capital gains track that can transform the after-tax value of equity awards for Israeli employees. But the statute leaves most of the critical grant design details unaddressed. This article explores how to navigate these gaps with a compliant design — offering the insights you need to shape your grant terms effectively.

Section 102 of Israel’s Income Tax Ordinance offers a favorable tax framework for employee equity within the Israeli regulatory landscape. While the Ordinance provides the technical roadmap —plan approval by the Israel Tax Authority (ITA) prior to any grants, deposit of awards with a mandatory trustee for tax withholding purposes, and a 24-month lock-up period from grant to sale - it leaves the finer points of your program largely undefined. This is where strategic planning comes in, helping you fill in the blanks and build a structure that truly delivers value.

Getting your grant design right starts with understanding the regulatory environment. Since the statute leaves much to interpretation, the Israel Tax Authority has filled the silence with its own set of guidelines—expressed through circulars, position papers, and specific rulings over the years. Navigating these official views is the secret to a model that stands up to scrutiny and avoids unwanted tax challenges.

In this article, we’ll walk you through the essential points and the common pitfalls to watch for, ensuring your planning is both smart and compliant.

Pitfall 1: Granting Awards Before Plan Submission for ITA Approval

This may seem obvious, yet it remains the most common mistake.

The plan needs to be filed with the ITA for approval at least 30 days before the first grant is made. There is no grace period, and no workaround. Grants made before the plan's submission simply do not qualify for the capital gains track. Full stop.

The problem is timing. When a company hires its first Israeli employees, equity is typically part of the offer package: signed, sealed, and delivered alongside the employment agreement. ITA plan review can take up to 90 days.

The solution is simple but requires discipline: submit the Israeli plan well before you expect to issue any awards. Even if no grants are currently on the horizon, having an approved plan on file means you can move quickly when the time comes.

Key Requirement: The plan needs to be filed with the ITA for approval at least 30 days before any grants are made.

Pitfall 2: Assuming Everyone Working for the Company Is Eligible

Not everyone who works for your company in Israel can participate. And the line is sharper than most global equity teams expect.

Section 102 covers two categories:

• Payroll employees
• Individual directors who invoice personally for their services

Anyone who provides services through a company, partnership, or other entity is excluded. Israeli tech professionals (developers, advisors, consultants) commonly work through a personal service company. They may function exactly like employees day to day. But if they invoice through an entity, they cannot participate in a Section 102 plan.

Before making any grant, verify how each participant is structured legally: their contract, how they invoice, and whether they operate through an entity. For directors, the analysis is equally fact specific. A director who invoices personally may qualify; one who operates through a management company does not.

Pitfall 3: Understanding the 409A Barrier and Israel’s Pricing Freedom

In the global race for talent, the ability to offer 'in-the-money' options is a massive lever—one that is nearly impossible for US startups due to 409A constraints. However, Israel’s Section 102 provides a significant competitive edge, allowing companies to bypass rigid FMV requirements and grant options with a low strike price, providing employees with immediate, tangible value from day one as the entire spread from grant to sale can qualify for capital gains treatment.

The advantage doesn't vanish when you ring the bell and go public—it simply evolves. While many global regimes tighten the screws once a company is listed, Israel’s Section 102 continues to offer a strategic 'hybrid' benefit. Since a public market provides a clear price tag, the law introduces a clever distinction: if you grant options at a discount—below the 30-day average trading price—that initial 'spread' is simply treated as salary at the time of sale.

But here is the real kicker: every cent of growth from that point forward can still qualify for the coveted capital gains track. It’s the ultimate recruitment tool for public firms, allowing them to bake in immediate, tangible value for top talent while still shielding the massive future upside from the heavy income tax rate. 

Private vs. Public Exercise Price Treatment

Private company: No minimum exercise price. Entire spread from grant to sale may qualify for capital gains treatment.
Public company: Measured against 30-day pre-grant average. Spread below base is taxed as employment income; appreciation above it can qualify for capital gains.

Pitfall 4: Using the Wrong Type of Equity Instrument

Section 102 requires a genuine equity instrument. The ITA has been specific about what that means. An award that does not meet all of the following conditions will not qualify:

• Newly issued ordinary shares, not a transfer from an existing shareholder.
• Full legal rights: voting (a proxy is acceptable), dividends, and participation.
• Non-redeemable. The company cannot be obligated or entitled to buy the shares back at a fixed price.
• Equity-classified, not liability-classified. Cash-settled instruments, phantom equity, and cash-settled SARs are all outside the framework.

Global plans must be adapted for the Israeli market to exclude cash-settled instruments, to ensure the equity classification is preserved.  

Pitfall 5: Tying Vesting to a Liquidity Event

This is the pitfall that most often catches sophisticated market players by surprise. The structure seems reasonable: equity instruments vest only if the company achieves a successful exit. Under Israeli tax rules, this approach creates problems.

ITA guidance requires vesting conditions to be fixed, measurable, and pre-defined at grant. Time-based vesting and objective performance milestones pass the test, but 'exit-only' vesting does not. In the eyes of the ITA, a grant contingent solely on a liquidity event fails the 'fixed and pre-defined' criteria. This represents a critical reclassification of the award into a standard cash-settled liability, stripping it of its capital gains status.

The strategic win lies in acceleration, not contingency. Smart Israeli structures don't tie vesting to an exit; they layer a high-impact acceleration mechanism on top of a standard time-based or performance schedule. This 'dual track' approach allows a qualifying IPO or acquisition to trigger immediate value for employees, providing the same liquidity punch without compromising the grant's coveted Section 102 equity status.

Notably, in March 2025 the Israel Tax Authority released a position paper that brought welcome clarity to the market regarding acceleration mechanisms. The ITA confirmed that when acceleration is built into the original grant terms, a single‑trigger acceleration should not undermine eligibility for capital gains treatment—provided that all statutory conditions are met. Even in a double‑trigger structure, there may still be an opportunity for the portion reflecting genuine value appreciation to benefit from the favorable capital gains tax rate. This clarification offers companies and employees alike a more predictable and optimized equity landscape.

Pitfall 6: Including Repurchase Rights in Grant Terms

Neither the company nor any related party can hold a repurchase right or a call option to buy back shares from the employee. Nor can the employee hold a put option that obligates the company to purchase. Standard shareholders’ agreement provisions (drag-along, tag-along, rights of first refusal) are not the issue.

The issue is bespoke repurchase mechanisms embedded in employment or equity agreements. The only recognized exception to this rule is a call option triggered specifically by the termination of employment. However, this is not a blanket permission; it is a strictly defined exception granted only through a formal tax ruling and remains subject to the explicit terms and limitations outlined in that ruling.

This is why standardized global documentation is a hidden trap. A template that thrives in the U.S. or Europe often carries 'buy-back' clauses that are strictly prohibited under Section 102. To neutralize this risk, global plans must be strategically optimized and updated—not just patched with a country addendum. The cleaner, more resilient solution is to strip away these prohibited mechanisms at their core, ensuring your documentation is built for Israeli compliance from the ground up.

The Bottom Line: Precision is a Strategic Advantage

Every pitfall boils down to one simple mistake: assuming that what works in one market will automatically fly in another. But here’s the reality: navigating the Israeli landscape is no more complex than any other high-stakes jurisdiction; it just requires a different lens.

While the rules of the game are specific, the potential reward is unparalleled. The ability to offer your team a legitimate, tax-optimized capital gains track is one of the most effective retention tools in the global tech scene. It is often the difference between a standard compensation package and a truly significant equity event for the employee.

The cost of a technical slip-up is high, turning a hard-earned capital gain into ordinary income overnight. However, when you build your plan on a foundation of localized expertise and optimized documentation, you aren't just "checking a box." You are ensuring that the value you intended to provide is fully realized and protected.

When the reward is a meaningful capital gains track for your employees, the precision is worth the effort. It is a long-term investment in your talent, and a standard of excellence for your company.

Note: the information presented herein provides a general overview for information purposes only and does not constitute financial, tax, legal, or any other advice. Parties reviewing the above recognize that each model has distinct, various tax and regulatory implications based on applicable jurisdiction and circumstances.

For additional insights into global equity compensation, including Israel-specific considerations, see the NASPP blog: Global Stock Compensation: Key Considerations and Resources.